EULAR recommendations for the management of antiphospholipid syndrome in adults

Cited by (1,254)

Items 801–900 of 1,254

1. Association between adherence to warfarin and thrombotic events in patients with antiphospholipid syndrome in Japan: A claims‐based retrospective cohort study
   Tserenlkham Byambajav, Takashi Waki, Katsuyuki Miura, Sachiko Tanaka‐Mizuno · 2021 · Pharmacoepidemiology and Drug Safety
2. A case of Libman–sacks endocarditis and the challenges of differentiating it from infective endocarditis
   Yi Lung Gan, Huzairi Sani · 2021 · Proceedings of Singapore Healthcare
3. Pharmacogenomics and Rheumatological Practice
   Chuanhui Xu, Khai Pang Leong · 2021 · Journal of Clinical Rheumatology and Immunology
4. Síndrome antifosfolipídico en pediatría: a propósito de un caso
   Miranda Fernández, Paula Tasso, Ignacio Tedeschini, Julia Lómez, María V López, Ariel Cheistwer · 2021 · Archivos Argentinos de Pediatria
5. Pharmacologic Treatment of Pulmonary Embolism
   Bruria Hirsh Raccah, Yosef Kalish, Refat Jabara, Eyal Herzog, Batia Roth · 2021 · Springer eBooks
6. Síndrome antifosfolípido no trombótico: manifestaciones inflamatorias hematológicas y neurológicas
   José-Carlos Álvarez-Feal, Mario Javier Giraldo Ardila, Tomás Urrego-Callejas · 2021 · IATREIA
7. Trimester-specific reference values for the anticardiolipin antibody by chemiluminescence immunoassay in healthy pregnancy
   Rui Gao, Xin-ai Yue, Wanrong Huang, Yu Fan, Lang Qin · 2022 · Clinical Chemistry and Laboratory Medicine (CCLM)
8. Antiphospholipid Syndrome and Stroke
   Kathryn Grimes, Adam P. Klein, Rakhee Lalla, Adeolu Morawo, Sana Somani, Mathew J. Woodward, John W. Cole · 2022 · IntechOpen eBooks
9. 01 Management of refractory lupus: place of biologics
   Bernardo Antonio Pons‐Estel, Andrea. Schwartz Doria, Murray B. Urowitz · 2019
10. “How we treat” clinical dilemmas in antiphospholipid syndrome: A case-based approach
    Irene Cecchi, Massimo Radin, Silvia Grazietta Foddai, Marta Arbrile, Alice Barinotti, Elena Rubini, Alessandro Morotti, Vittorio Pengo, Dario Roccatello, Savino Sciascia · 2022 · European Journal of Internal Medicine
11. Features of clinical manifestations, course, outcomes and health related quality of life in patients with systemic lupus erythematosus in the Republic of Kazakhstan
    B. Issayeva, Elena Aleksandrovna Aseeva, M. M. Saparbayeva et al. · 2022 · Rheumatology Science and Practice
12. Mitral Valve Replacement for Enlarged Libman-Sacks Endocarditis in a Patient with Persistent Primary Antiphospholipid Syndrome and Recurrent Stroke: A Case Report
    Katsuya Takeuchi, Tesseki Izumi, Hitoki Nanaura, Nanami Yamada, Yoshihiro Hayata, Chiho Obayashi, Kazuma Sugie · 2023 · American Journal of Case Reports
13. [Chinese expert consensus on the diagnosis and treatment of thromboembolism in patients with immune thrombocytopenia (2023)].
    2023 · PubMed
14. Reproductive Health in the Rheumatic Diseases
    Julia Sun, Laura Andréoli, Jane E. Salmon, Meghan Clowse, Caroline Gordon, Jill P. Buyon, Rosalind Ramsey‐Goldman, Lisa R. Sammaritano · 2023 · Springer eBooks
15. Unexplained fetal death, pre-eclampsia and fetal growth restriction in pregnancy: Who is screened for antiphospholipid syndrome?
    Clothilde Gros, Tiphaine Barral, Arthur Mageau, Pascale Nicaise‐Roland, Valérie Vivier, T. Papo, Agnès Bourgeois-Moine, Tiphaine Miquel Goulenok, Karim Sacré · 2023 · Thrombosis Research
16. Antikoagulation und Thrombozytenfunktionshemmung
    Oliver Zeitz, Laura Wernecke, Nicolas Feltgen · 2023 · Spektrum der Augenheilkunde
17. Modulation of the activation of endothelial nitric oxide synthase and nitrosative stress biomarkers by aspirin triggered lipoxins: A possible mechanism of action of aspirin in the antiphospholipid syndrome
    Manuel Granada‐Gómez, Manuela Velásquez, Carolina Rúa-Molina, Sebastián San Martín, Carlos Escudero, Ángela M. Álvarez, Ángela Patricia Cadavid · 2023 · American Journal of Reproductive Immunology
18. Cryptogenic stroke. Part 4: Antiphospholipid syndrome and cancer
    Aleksey A. Kulesh, Anastasia V. Belopasova, Dmitry A. Demin · 2023 · Meditsinskiy sovet = Medical Council
19. A Patient with Recurrent Strokes: Approach to Coagulopathy
    Gabriel Zúñiga Salazar, Pranav Kandula, Hardy Sandefur, Alfonso Javier Tafur · 2023 · TH Open
20. Should we be targeting type 1 interferons in antiphospholipid syndrome?
    Gabrielle de Mello Santos, Artur Saldanha, Fernanda Andrade Orsi · 2023 · Clinical Immunology
21. Managing Anticoagulation and Dual Antiplatelet Therapy in Patients with Active Bleed or Upcoming Procedure: A Scoping Review
    Julia L. Berkowitz, Matthew A. Taylor, Fabio V. Lima, Omar N. Hyder · 2023 · Journal of Brown Hospital Medicine
22. Thrombosis and APS: Lessons Learned from Another Black Swan Tale
    Sofia Camerlo, Irene Cecchi, Silvia Grazietta Foddai, Massimo Radin, Alice Barinotti, Alessandro Morotti, Dario Roccatello, Savino Sciascia · 2023 · Lupus
23. Diagnostic Challenges of Systemic Lupus Erythematosus
    Ana Correia de Sá, Marta Batista, Ana Lúcia Ferreira · 2023 · Cureus
24. Case 38-2023: A 68-Year-Old Woman with Abnormal Movements and Confusion
    Bart K. Chwalisz, Hillary R. Kelly, Alice Weaver Flaherty · 2023 · New England Journal of Medicine
25. Was erwartet mich und mein Kind?
    Yvette Meißner · 2024 · Arthritis und Rheuma
26. Fulminant Recurrent Thrombosis in a Patient with Catastrophic Antiphospholipid Syndrome and Its Thirty-Day Outcome
    Pierpaolo Di Micco, Maurizio Dorato, Maurizio Latte · 2024 · Immuno
27. Sub-segmental pulmonary thromboembolism in a pregnant woman with generalized lupus erythematosus, triple-negative antiphospholipid syndrome, and protein C deficiency. A case report
    Arlin Montoya-Rodríguez, M Duarte, Sayonara Sandino López · 2024 · Radiology Case Reports
28. Laboratory assessment of antiphospholipid syndrome: Laboratory data
    Camilla Jannie Kobylecki, Signe Vedel‐Krogh, Shoaib Afzal, Jens Peter Goetze · 2024 · International Journal of Laboratory Hematology
29. Lupus and the nervous system
    Alexandra C. Legge, John G. Hanly · 2024 · Elsevier eBooks
30. Lupus eritematoso sistémico
    Christophe Richez, Estibaliz Lazaro, Julien Sénéschal, Lionel Couzi · 2024 · EMC - Aparato Locomotor
31. Cerebral vein thrombosis: from risk factors to recanalization and clinical outcomes. A review
    Tatiana Yu. Batenkova · 2024 · Consilium Medicum
32. Transcatheter mitral valve-in-valve for pregnancy with anti-phospholipid syndrome: a case report
    Zhenzhong Wang, Yuxin Li, Shuo Xiao · 2024 · Journal of Cardiothoracic Surgery
33. Stability of Anticoagulation Following Acenocoumarin in Stroke Patients: Role of Pharmacogenomics and Acquired Factors
    A. Dubey, J. Kalita, M. Nizami, Surendra Kumar, U. Misra · 2024 · Annals of Indian Academy of Neurology
34. The successful management of stroke in Evans syndrome by anticoagulation with warfarin, intravenous immunoglobulin (IVIG), and high-dose corticosteroid
    Toshiaki Takahashi, Kensuke Takaoka, Kelsey Kwong · 2024 · European Journal of Case Reports in Internal Medicine
35. The Etiology of Intracranial Artery Stenosis in Autoimmune Rheumatic Diseases: An Observational High-Resolution MR Imaging Study
    Shun Li, Qiuyu Yu, Yangzhong Zhou et al. · 2024 · American Journal of Neuroradiology
36. Impact of Lupus Anticoagulant on INR Using Recombinant Prothrombin Time Reagent
    Fatmawati Kamal, Halimatun Radziah Othman · 2024 · American Journal of Case Reports
37. Antiphospholipid Syndrome
    Giuseppe Barilaro, Gerard Espinosa, Ricard Cervera · 2024 · Springer eBooks
38. Antiphospholipid Syndrome Patient with Libman-Sacks Endocarditis
    Andy Nugraha, Awalia Awalia, Rendra Mahardika Putra · 2025 · Pharmacognosy Journal
39. Patients with antiphospholipid antibodies preferentially seek health information from physicians: a cross-sectional online patient quantitative survey
    Alexandra O. Kobza, Francesca S. Cardwell, Susan J. Elliott · 2025 · Rheumatology International
40. Hepatitis E-Induced Worsening of Antiphospholipid Syndrome With Extensive Thrombosis: A Case Report
    Abraham Karimi, Sonal Prasad, EDSEL EMBRY · 2025 · Cureus
41. Plasmapheresis for lowering the risks of placenta-associated complications in antiphospholipid syndrome
    Nart F. Kuneshko, V. V. Kim, Ляднова Елизавета Михайловна, A. R. Metkina, M. N. Velieva, Лазарчук Арина Владимировна, Victoria O. Bitsadze, Maria V. Tretyakova, Dmitry V. Blinov · 2025 · Obstetrics Gynecology and Reproduction
42. Bibliometric analysis of systemic lupus erythematosus during pregnancy from 2003 to 2024
    Xinyan Zou, Xinfu Zou, Qiaoqiao Liu · 2025 · Immunological Medicine
43. Vascular liver disorders in patients with antiphospholipid syndrome: a national retrospective multicentre study
    M. Katims, Marc Pineton de Chambrun, Cécile Yelnik et al. · 2025 · Lara D. Veeken
44. Comprehensive Clinical and Behavioral Characteristics of Mild Cognitive Impairment According to Amyloid Positivity: A Large Multi-Center Korean Cohort
    Seung Ae Kim, Yeshin Kim, Duk Lyul Na, Sang Won Seo, Hyemin Jang · 2025 · Dementia and Neurocognitive Disorders
45. Effect of anti-nuclear antibody positivity with negative specific anti-extractable anti-nuclear antibodies on IVF and ICSI embryological outcomes: potential role of sperm concentration
    Kai Ding, Xin Li, Wei Jiang · 2025 · Reproductive BioMedicine Online
46. Abortion adverse events associated with adalimumab, etanercept, ustekinumab, and dupilumab during pregnancy: A pharmacovigilance study based on FDA adverse event reporting system
    Qian Liu, Yang Wang, Panwei Hu, Peizhi He · 2025 · Drug Discoveries & Therapeutics
47. Nécrose hémorragique bilatérale des surrénales sous APIXABAN : penser au syndrome des antiphospholipides ?
    Virginie Lavoipierre, Marjolaine Talbot, Caroline Soubrier et al. · 2019 · La Revue de Médecine Interne
48. Recurrent Pregnancy Loss: Investigations and Interventions
    Vinicius M. Lopes, Murilo C. Souza-Oliveira, Amanda Evelyn Cruvinel Goulart, Eduardo S. Pimentel, Natalia I. Zavattiero Tierno, Tatianna Quintas F. Ribeiro, Cristina T. Medina, V. Lombardo Castro, Leilane Gabriele Noleto Lima, Anna Luiza M. Souza et al. · 2019 · IntechOpen eBooks
49. Practical approaches to laboratory assessment of risk of reсcurent thrombosis in antiphospholipid syndrome
    Olga Yu. Tkachenko, Sergey Vladimirovich Lapin, A. V. Маzing, Vladimir Leonidovich Emanuel · 2020 · Medical alphabet
50. Escaping the catch 22 of lupus anticoagulant testing
    Pernille Just Vinholt, Søren Andreas Just · 2020 · RMD Open
51. A Nephro-Obstetric outpatient clinic model
    Estela Nogueira, Rita Calça, Iolanda Godinho · 2020 · Portuguese Journal of Nephrology & Hypertension
52. Profilaxis de la enfermedad tromboembólica venosa durante el embarazo
    Raquel Barba, D. Joya Seijo · 2020 · Revista Clínica Española
53. Insight into the Therapeutic-Switching of Antimalarial Drugs Chloroquine and Hydroxychloroquine for the Pharmacotherapy of COVID-19; A Mini-Review
    Zainab Bahardeen · 2020 · Biomedical Journal of Scientific & Technical Research
54. Revisiting cardiac safety of hydroxychloroquine in rheumatological diseases during COVID-19 era: Facts and myths
    Shivraj Padiyar, Debashish Danda · 2020 · European Journal of Rheumatology
55. Cloroquina: mecanismos de ação, efeitos colaterais e revisão de estudos sobre seu uso contra o SARS-CoV-2
    Diogo Martins Ribeiro, André Tomaz Terra Júnior, Edson Rodrigues Cavalcante · 2020 · South American Sciences
56. Outcomes in patients with nontriple antiphospholipid syndrome (APS) anticoagulated with rivaroxaban
    Thura Win Htut, Denis Milne, Mohammed Masudul Hassan Khan · 2021 · International Journal of Laboratory Hematology
57. Antiphospholipidic Antibodies in SARS-CoV2 Infection: Still a Lot to Learn
    Ciprian Jurcuț, Savino Sciascia · 2021 · Internal Medicine
58. Svangerskapskomplikasjoner hos kvinner med systemisk lupus erythematosus
    Carina Gøtestam Skorpen, Kjell Åsmund Salvesen, Øyvind Palm · 2021 · Tidsskrift for Den norske legeforening
59. Antiphospholipid Syndrome and Pregnancy-Diagnosis, Complications and Management: An Overview
    Panagiotis N. Tsikouras, Christina Tsiggalou, Αnastasia Bothou et al. · 2021 · IntechOpen eBooks
60. The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part II
    N.L. Kozlovskaya, Sergey K. Solovyev, Elena Aleksandrovna Aseeva · 2021 · Modern Rheumatology Journal
61. A Review on Hydroxychloroquine Drug: to Combat COVID-19
    2020 · Letters in Applied NanoBioScience
62. Antiphospholipid syndrome: the burden of inadequate anticoagulation management
    Kladoum Nassarmadji, Alejandro J. Brigante, C. Larroche · 2021 · Clinical and Experimental Rheumatology
63. Enfoque del síndrome antifosfolipidos en el embarazo
    María Fernanda Zapata Marín, Gabriela Michelle Pinzón Reyes, Erika Nathaly Cabrera Vega · 2022 · Ciencia Latina Revista Científica Multidisciplinar
64. Digital ulcers as presenting symptom of secondary antiphospholipid syndrome
    Karen Cravero, Austin John Maddy, Kiran Motaparthi · 2022 · JAAD Case Reports
65. Trombosis venosa de retina. Auditoría de un programa de atención especializada
    José Antonio Rueda-Camino, Francisco Javier Gimena-Rodríguez, M.A. Domínguez-Sepúlveda, M. Bolzoni, A.I. Pastor-Vivas, María Angelina-García, D. Joya Seijo, Davinia Trujillo-Luque, Diego Losada-Bayo, Raquel Barba · 2022 · Revista Clínica Española
66. Characteristics of Novel Anticoagulants versus Vitamin K Antagonists in the Ventricular Mural Thrombus
    Qing Yang, Yan Liang, Xin Quan · 2023 · Reviews in Cardiovascular Medicine
67. Bilateral pulmonary embolism associated with peripheral blood eosinophilia and positive antiphospholipid antibodies in a patient with cellulitis
    Han Naung Tun, May Thu Kyaw, Daryna Chernikova · 2023 · Clinical Case Reports
68. Medikamentöse Thromboseprophylaxe in der Schwangerschaft
    Christina Hart, Birgit Linnemann · 2023 · Phlebologie
69. L’hydroxychloroquine, une vieille molécule toujours d’actualité
    Christophe Richez · 2023 · Revue du Rhumatisme
70. Que penser des nouveaux critères de classification ACR/EULAR pour le syndrome des antiphospholipides ?
    G. Guettrot-Imbert, Anne Murarasu, Véronique Le Guern · 2023 · La Revue de Médecine Interne
71. Correspondence on ‘EULAR recommendations for the management of antiphospholipid syndrome in adults‘
    Zhuochao Zhou, Wang Fan, Yue Sun et al. · 2020 · Annals of the Rheumatic Diseases
72. Overcoming Barriers to Warfarin Patient Self-Management (PSM) in the US Healthcare System: Implementation Trial Study Protocol
    Heeseung Hong, Aaron S. Wilson, Aubrey E. Jones, Sara R. Vazquez, Spencer Gilbert, Daniel C. Malone, Nathorn Chaiyakunapruk, Jordan B. King, Geoffrey D. Barnes, Katelyn Woods Sylvester et al. · 2025 · medRxiv
73. Recurrent Thrombosis and Hemorrhagic events in a Large Single-center Primary Antiphospholipid Syndrome Cohort: Results from APS-Rio Cohort After Nearly 1,000 Patients-year of Follow-up
    Flávio Signorelli, Gustavo Guimarães Moreira Balbi, Vinícius Pereira Bastos, Thaiana Reis Alves da Fonseca Carvalho, Evandro Mendes Klumb, Roger A. Levy · 2025 · SSRN Electronic Journal
74. Complications thrombotiques et hémorragiques au cours de la grossesse et du post-partum chez 119 patientes porteuses d’un syndrome des antiphospholipides et incluses dans le GR2
    Anne Murarasu, G. Guettrot-Imbert, Véronique Le Guern et al. · 2019 · La Revue de Médecine Interne
75. Facteurs de risque de morbi-mortalité néonatale chez les patientes porteuses d’un syndrome des antiphospholipides incluses dans l’étude prospective du GR2
    Anne Murarasu, G. Guettrot-Imbert, Véronique Le Guern et al. · 2019 · La Revue de Médecine Interne
76. Infarto agudo de miocardio como manifestación inicial de síndrome antifosfolípido primario: Reporte de Caso
    Laura Pedraza, Renato A. Guzmán · 2020 · Revista Cuarzo
77. Management of antiphospholipid syndrome in adults: The European League Against Rheumatism (EULAR) recommendations
    Mirjana Veselinović, Aleksandra Tomic Lucic, Vladimir Lj. Jakovljevic, Ana Aničić · 2019 · Medicinski casopis
78. Antiphospholipid Syndrome: Nephrologists’ Perspective
    Noha Abdou, Sabry Abd Allah Shoeib, Enas Sobhy Zahran · 2020 · Open Journal of Internal Medicine
79. Levels of toll-like receptors 2 and 4 in serum of men with postinfarction cardiosclerosis and its relationship with antiphospholipid syndrome components
    M. S. Nazarova, Mykola Stanislavchuk, L. V. Burdeina · 2019 · Reports of Vinnytsia National Medical University
80. Contributions of the lupus register of the Spanish Society of Rheumatology (RELESSER) to the knowledge of systemic lupus erythematosus in Spain
    Íñigo Rúa-Figueroa Fernández de Larrinoa, José María Pego‐Reigosa, J. López-Longo et al. · 2020 · Reumatología Clínica (English Edition)
81. Diagnostik und Therapie des Antiphospholipidsyndroms
    Stella Jacobi, Wolfgang Miesbach · 2020 · InFo Hämatologie + Onkologie
82. Successful secondary thromboprophylaxis with direct oral anticoagulants for a patient with catastrophic antiphospholipid syndrome
    Nhan Hieu Dinh, Suzanne Monivong Cheanh Beaupha · 2020 · Medicine
83. The nervous system in systemic lupus erythematosus
    David P J Hunt · 2020 · Elsevier eBooks
84. Sicherheitsmanagement der Therapie mit Antimalariamitteln: was bedeuten die neuen Empfehlungen für die Praxis?
    Denitsa Hadjiski, Christoph Fiehn · 2020 · Aktuelle Rheumatologie
85. Therapie des SLE 2020: aktueller Stand nach den EULAR-Empfehlungen 2019
    Johanna Mücke, Rebecca Fischer‐Betz · 2020 · Aktuelle Rheumatologie
86. Sindrome da anticorpi antifosfolipidi
    Alexis Mathian, M. Hié, Micheline Pha, Zahir Amoura · 2020 · EMC - AKOS - Trattato di Medicina
87. 26 Refractory and/or catastrophic APS in SLE
    Ricard Cervera · 2020 · Abstracts
88. 25 Refractory musculoskeletal manifestations
    Bernardo Antonio Pons‐Estel · 2020 · Abstracts
89. Síndrome Antifosfolípido Obstétrico
    Gabriel Calderón Valverde, Mauricio Cordero Alfaro · 2020 · Revista Clínica Escuela de Medicina UCR-HSJD
90. Comment on: EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies: reply
    Cecilia Beatrice Chighizola, Francesca Pregnolato · 2020 · Lara D. Veeken
91. Comment on: EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies
    Joydeep Samanta, Debashish Mishra, Arghya Chattopadhyay · 2020 · Lara D. Veeken
92. Évaluation prospective d’une réunion de concertation pluridisciplinaire dédiée aux pathologies inflammatoires et vasculaires lors de la grossesse : la RCP « PREGNANT » au CHU de Bordeaux
    J.L. Blondeel, Aurélien Mattuizzi, Yahsou Delmas, S. Skopinski, Christophe Richez, Patrick Blanco, Loı̈c Sentilhes, Estibaliz Lazaro · 2020 · Gynécologie Obstétrique Fertilité & Sénologie
93. Minor stroke with bilateral acute infarctions and combined vascular anomalies: A complex case report
    Fabrizio Giammello, Cristina Dell’Aera, Francesco Grillo et al. · 2020 · Heliyon
94. Deficiency of natural anticoagulants: how should we manage cardiovascular prevention?
    Francesco Paciullo, Andrea Baccolo · 2021 · Internal and Emergency Medicine
95. Antiphospholipid Syndrome in a Patient with Systemic Lupus Erythematosus Elements
    Martina Špero · 2021 · Springer eBooks
96. A significant improvement of thromboses treated by a new oral anticoagulant in an 11-year-old girl with systemic lupus erythematosus associated antiphospholipid syndrome: A case report
    Yen-Jung Chiang, Ya‐Chiao Hu, Bor‐Luen Chiang · 2021 · Lupus
97. Autoantibodies and Kidney Diseases
    Rezan Topaloğlu, Tanja Kersnik Levart, Michio Nagata · 2021 · Pediatric Nephrology
98. Clinical Relevance of Antiphospholipid Antibodies Levels During the Course of Severe COVID-19
    Soumia Nachate, Mahassine Moukaouim, Loubna Darfaoui et al. · 2021 · International Journal of Immunology
99. Antiphospholipid-Syndrom bei Kindern und Jugendlichen
    Christian Michael Hedrich, Tilmann Kallinich · 2021 · Springer Reference Medizin
100. The place of hydroxychloroquine in modern dermatology
     Aleksandra Dańczak‐Pazdrowska, Adriana Polańska · 2021 · Dermatology Review